Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00710931 · ClinicalTrials.gov registry record · Phase 4
Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00710931 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 35 participants.
The verdict
NCT00710931, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective of this study is to prospectively evaluate the visual parameters in a series of patients after phacoemulsification cataract surgery in a series of patients bilaterally implanted with the AcrySof® ReSTOR® Aspheric +3.0 Intraocular Lens (IOL).
Interventions
- DEVICE AcrySof ReSTOR Aspheric IOL model SN6AD1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00710931
The ClinicalTrials.gov registry entry for NCT00710931 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AcrySof ReSTOR Aspheric IOL model SN6AD1 is the first listed.
NCT00710931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00710931 about?
NCT00710931 is a clinical study titled "Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1". The objective of this study is to prospectively evaluate the visual parameters in a series of patients after phacoemulsification cataract surgery in a series of patients bilaterally implanted with the AcrySof® ReSTOR® Aspheric +3.0 Intraocular Lens (IOL).
What is the current status of trial NCT00710931?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2008-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00710931?
The interventions under investigation include: AcrySof ReSTOR Aspheric IOL model SN6AD1 (DEVICE).
Who is sponsoring clinical trial NCT00710931?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.